Correction to: De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma.

ABSTRACT:

SUBMITTER: Xu D 

PROVIDER: S-EPMC12905169 | biostudies-literature | 2026 Feb

REPOSITORIES: biostudies-literature